Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$383M |
| 2 |
Costco
COST
|
+$267M |
| 3 |
Pfizer
PFE
|
+$231M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$227M |
Top Sells
| 1 |
CVS Health
CVS
|
+$258M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
+$216M |
| 4 |
Charter Communications
CHTR
|
+$142M |
| 5 |
TE
TECO ENERGY INC
TE
|
+$136M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.63% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
CareTrust REIT
CTRE
$7.64B
| $2.39M | ﹤0.01% |
161,400
-315,500
| -66% | -$4.66M |
|
|
STCN
2077
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $2.39M | ﹤0.01% |
155,812
-980
| -0.6% | -$15K |
|
2078
Minerva Neurosciences
NERV
$15.1M
| $2.38M | ﹤0.01% |
21,063
-4,137
| -16% | -$467K |
|
2079
Brookfield Renewable
BEP
$7.29B
| $2.38M | ﹤0.01% |
145,037
-105,476
| -42% | -$1.73M |
|
|
MGI
2080
DELISTED
MoneyGram International, Inc. New
MGI
| $2.38M | ﹤0.01% |
334,704
+12,013
| +4% | +$85.3K |
|
2081
Ameriprise Financial
AMP
$46.5B
| $2.38M | ﹤0.01% |
+23,800
| New | +$2.38M |
|
|
TBRA
2082
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $2.37M | ﹤0.01% |
59,666
+22,401
| +60% | +$890K |
|
|
PWOD
2083
DELISTED
Penns Woods Bancorp
PWOD
| $2.37M | ﹤0.01% |
79,950
+7,350
| +10% | +$218K |
|
2084
Global Indemnity Group
GBLI
$428M
| $2.37M | ﹤0.01% |
79,764
-6,100
| -7% | -$181K |
|
2085
Gogo Inc
GOGO
$1.31B
| $2.37M | ﹤0.01% |
214,300
-404,700
| -65% | -$4.47M |
|
2086
TIM SA
TIMB
$10.3B
| $2.37M | ﹤0.01% |
193,238
-250,300
| -56% | -$3.06M |
|
2087
Motorcar Parts of America
MPAA
$307M
| $2.36M | ﹤0.01% |
82,100
-18,700
| -19% | -$538K |
|
|
EGAS
2088
DELISTED
Gas Natural Inc.
EGAS
| $2.36M | ﹤0.01% |
307,800
+62,200
| +25% | +$477K |
|
2089
Natera
NTRA
$23.7B
| $2.35M | ﹤0.01% |
211,900
+126,100
| +147% | +$1.4M |
|
2090
Seneca Foods Class A
SENEA
$741M
| $2.35M | ﹤0.01% |
83,200
+22,600
| +37% | +$638K |
|
|
SMMF
2091
DELISTED
Summit Financial Group, Inc.
SMMF
| $2.35M | ﹤0.01% |
122,635
+10,162
| +9% | +$195K |
|
|
CSW
2092
CSW Industrials, Inc.
CSW
$4.16B
| $2.35M | ﹤0.01% |
72,400
+47,800
| +194% | +$1.55M |
|
|
RC
2093
Ready Capital
RC
$703M
| $2.34M | ﹤0.01% |
162,200
-22,400
| -12% | -$323K |
|
|
RBS.PRH.CL
2094
DELISTED
Royal Bank Of Scotland Group
RBS.PRH.CL
| $2.34M | ﹤0.01% |
91,909
+16,929
| +23% | +$431K |
|
2095
Consumer Portfolio Services
CPSS
$198M
| $2.34M | ﹤0.01% |
508,800
+23,100
| +5% | +$106K |
|
|
GBT
2096
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.33M | ﹤0.01% |
+101,200
| New | +$2.33M |
|
|
TECD
2097
DELISTED
Tech Data Corp
TECD
| $2.33M | ﹤0.01% |
+27,542
| New | +$2.33M |
|
2098
Materials Select Sector SPDR Fund
XLB
$5.47B
| $2.33M | ﹤0.01% |
+48,800
| New | +$2.33M |
|
|
NW.PRC.CL
2099
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $2.32M | ﹤0.01% |
90,300
+7,000
| +8% | +$180K |
|
|
ADAP
2100
Adaptimmune Therapeutics
ADAP
$17.4M
| $2.32M | ﹤0.01% |
328,700
+139,500
| +74% | +$983K |
|